The UK's competition watchdog has ordered vets to cap prescription fees at £21 and proposed a cost comparison website, after finding consumers faced huge price rises and were 'left in the dark' over bills. The Competition and Markets Authority (CMA) said public satisfaction with the cost of services was 'low' following a two-and-a-half-year investigation into the £6.7bn market, which found 'there is not strong competition between veterinary businesses', with large chains dominant.
The watchdog said vets must now inform pet owners that medicines may be cheaper online and that they can obtain a prescription to save money. Written prescription fees will be capped at £21 for the first medicine and £12.50 for any additional drugs, a measure the CMA estimates could save pet owners hundreds of pounds. However, the cap is less severe than the £16 limit previously proposed.
Martin Coleman, chair of the independent inquiry group, stated: 'Too often, people are left in the dark about who owns their practice, treatment options and prices – even when facing bills running into thousands of pounds. Our measures mean it will be made clear to pet owners which practices are part of large groups, which are charging higher prices, and for the first time, vet businesses will be held to account by an independent regulator.'
Other legally binding measures include price lists and a comparison website to increase competition and drive down costs. Large groups must make clear that individual practices are part of a chain. Pet owners using chain vets can expect changes before Christmas, including standard price lists. Practices must provide a written estimate for any treatment expected to cost £500 or more, excluding emergencies, plus an itemised bill.
The CMA found average vet service prices rose 63% between 2016 and 2023, 'sharply and much faster than general inflation', with no strong link to quality investments. More than 60% of practices are owned by six large groups: CVS, Pets at Home, Medivet, IVC, VetPartners, and Linnaeus. The CMA labelled the 60-year-old regulatory regime 'outdated', noting key parts of the system are unregulated where concerns have arisen.